Difference between revisions of "Agomelatine-moclobemide"

From Psychiatrienet
Jump to: navigation, search
 
(2 intermediate revisions by one other user not shown)
Line 2: Line 2:
 
| from = agomelatine  
 
| from = agomelatine  
 
| to = moclobemide  
 
| to = moclobemide  
| stop = {{StopAgomelatine}}
+
| stop =  
 +
* ''' Day 1: ''' Stop agomelatine
 
| start =  
 
| start =  
 +
* ''' Day 2:''' Start administration of moclobemide with 50% of target dose
 +
* ''' Day 8:''' Increase moclobemide dosages to 100%
 +
| info =
 
* A wash-out period is not necessary.
 
* A wash-out period is not necessary.
* Start administration of moclobemide the next day in a normal dosage of 300 mg/day.
 
 
 
}}
 
}}

Latest revision as of 15:19, 16 June 2016

Agomelatine
Type Antidepressant
Group other
links
ATC-code N06AX22
EMEA valdoxan
PubChem 82148
PubMed Agomelatine
Kompas (Dutch) Agomelatine
Wikipedia Agomelatine
Moclobemide
Type Antidepressant
Group MAO-I
links
Medscape Moclobemide
PubChem 4235
PubMed Moclobemide
Kompas (Dutch) Moclobemide
Wikipedia Moclobemide

Switch medication from agomelatine to moclobemide.

Nietinrijdenbord.png Stop agomelatine
  • Day 1: Stop agomelatine
Eenrichtingbord.png Start moclobemide
  • Day 2: Start administration of moclobemide with 50% of target dose
  • Day 8: Increase moclobemide dosages to 100%
Infobord.png More information
  • A wash-out period is not necessary.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.